Nicholas W Keiser1, John F Engelhardt. 1. Department of Anatomy and Cell Biology, University of Iowa Carver College of Medicine, Iowa City, Iowa 52242-1109, USA.
Abstract
PURPOSE OF REVIEW: Cystic fibrosis is the first human genetic disease to benefit from the directed engineering of three different species of animal models (mice, pigs, and ferrets). Recent studies on the cystic fibrosis pig and ferret models are providing new information about the pathophysiology of cystic fibrosis in various organ systems. Additionally, new conditional cystic fibrosis transmembrane conductance regulator (CFTR) knockout mice are teaching unexpected lessons about CFTR function in surprising cellular locations. Comparisons between these animal models and the human condition are key to dissecting the complexities of disease pathophysiology in cystic fibrosis. RECENT FINDINGS: Cystic fibrosis pigs and ferrets have provided new models to study the spontaneous development of disease in the lung and pancreas, two organs that are largely spared overt spontaneous disease in cystic fibrosis mice. New cystic fibrosis mouse models are now interrogating CFTR functions involved in growth and inflammation at an organ-based level using conditional knockout technology. Together, these models are providing new insights on the human condition. SUMMARY: Basic and clinical cystic fibrosis research will benefit greatly from the comparative pathophysiology of cystic fibrosis mice, pigs, and ferrets. Both similarities and differences between these three cystic fibrosis models will inform pathophysiologically important mechanisms of CFTR function in humans and aid in the development of both organ-specific and general therapies for cystic fibrosis.
PURPOSE OF REVIEW: Cystic fibrosis is the first humangenetic disease to benefit from the directed engineering of three different species of animal models (mice, pigs, and ferrets). Recent studies on the cystic fibrosispig and ferret models are providing new information about the pathophysiology of cystic fibrosis in various organ systems. Additionally, new conditional cystic fibrosis transmembrane conductance regulator (CFTR) knockout mice are teaching unexpected lessons about CFTR function in surprising cellular locations. Comparisons between these animal models and the human condition are key to dissecting the complexities of disease pathophysiology in cystic fibrosis. RECENT FINDINGS:Cystic fibrosispigs and ferrets have provided new models to study the spontaneous development of disease in the lung and pancreas, two organs that are largely spared overt spontaneous disease in cystic fibrosismice. New cystic fibrosismouse models are now interrogating CFTR functions involved in growth and inflammation at an organ-based level using conditional knockout technology. Together, these models are providing new insights on the human condition. SUMMARY: Basic and clinical cystic fibrosis research will benefit greatly from the comparative pathophysiology of cystic fibrosismice, pigs, and ferrets. Both similarities and differences between these three cystic fibrosis models will inform pathophysiologically important mechanisms of CFTR function in humans and aid in the development of both organ-specific and general therapies for cystic fibrosis.
Authors: Xingshen Sun; Hongshu Sui; John T Fisher; Ziying Yan; Xiaoming Liu; Hyung-Ju Cho; Nam Soo Joo; Yulong Zhang; Weihong Zhou; Yaling Yi; Joann M Kinyon; Diana C Lei-Butters; Michelle A Griffin; Paul Naumann; Meihui Luo; Jill Ascher; Kai Wang; Timothy Frana; Jeffrey J Wine; David K Meyerholz; John F Engelhardt Journal: J Clin Invest Date: 2010-08-25 Impact factor: 14.808
Authors: Gregory S Harmon; Darren S Dumlao; Damian T Ng; Kim E Barrett; Edward A Dennis; Hui Dong; Christopher K Glass Journal: Nat Med Date: 2010-02-14 Impact factor: 53.440
Authors: David A Stoltz; David K Meyerholz; Alejandro A Pezzulo; Shyam Ramachandran; Mark P Rogan; Greg J Davis; Robert A Hanfland; Chris Wohlford-Lenane; Cassie L Dohrn; Jennifer A Bartlett; George A Nelson; Eugene H Chang; Peter J Taft; Paula S Ludwig; Mira Estin; Emma E Hornick; Janice L Launspach; Melissa Samuel; Tatiana Rokhlina; Philip H Karp; Lynda S Ostedgaard; Aliye Uc; Timothy D Starner; Alexander R Horswill; Kim A Brogden; Randall S Prather; Sandra S Richter; Joel Shilyansky; Paul B McCray; Joseph Zabner; Michael J Welsh Journal: Sci Transl Med Date: 2010-04-28 Impact factor: 17.956
Authors: Ziying Yan; Xingshen Sun; Idil A Evans; Scott R Tyler; Yi Song; Xiaoming Liu; Hongshu Sui; John F Engelhardt Journal: Hum Gene Ther Date: 2013-09 Impact factor: 5.695
Authors: Xingshen Sun; Alicia K Olivier; Yaling Yi; Christopher E Pope; Hillary S Hayden; Bo Liang; Hongshu Sui; Weihong Zhou; Kyle R Hager; Yulong Zhang; Xiaoming Liu; Ziying Yan; John T Fisher; Nicholas W Keiser; Yi Song; Scott R Tyler; J Adam Goeken; Joann M Kinyon; Matthew C Radey; Danielle Fligg; Xiaoyan Wang; Weiliang Xie; Thomas J Lynch; Paul M Kaminsky; Mitchell J Brittnacher; Samuel I Miller; Kalpaj Parekh; David K Meyerholz; Lucas R Hoffman; Timothy Frana; Zoe A Stewart; John F Engelhardt Journal: Am J Pathol Date: 2014-03-15 Impact factor: 4.307
Authors: Nicholas W Keiser; Susan E Birket; Idil A Evans; Scott R Tyler; Adrianne K Crooke; Xingshen Sun; Weihong Zhou; Joseph R Nellis; Elizabeth K Stroebele; Kengyeh K Chu; Guillermo J Tearney; Mark J Stevens; J Kirk Harris; Steven M Rowe; John F Engelhardt Journal: Am J Respir Cell Mol Biol Date: 2015-06 Impact factor: 6.914
Authors: Xingshen Sun; Yaling Yi; Bo Liang; Yu Yang; Nan He; Katie Larson Ode; Aliye Uc; Kai Wang; Katherine N Gibson-Corley; John F Engelhardt; Andrew W Norris Journal: J Cyst Fibros Date: 2019-02-07 Impact factor: 5.482
Authors: William R Hunt; Susu M Zughaier; Dana E Guentert; Melissa A Shenep; Michael Koval; Nael A McCarty; Jason M Hansen Journal: Am J Physiol Lung Cell Mol Physiol Date: 2013-10-04 Impact factor: 5.464